Atorvastatin
5 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
5
Ongoing
2
Recruiting
1
Completed
3
Sites
201
Countries
11
Endpoints
16
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 16 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 0 of 16 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
No normalized metric codes are available for this asset.
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
5 of 5
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| PREVENTABLEPragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults | Atorvastatin Mixed / unspecified dementia | Age ≥75 | Ph 4 | Recruiting | 103 | Dec 2026 | 3 | |
| NCT00151502To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients. | Atorvastatin Alzheimer’s disease | Alzheimer's disease | Ph 3 | Completed | 99 | Jul 2007 | - | |
| STAREE-MindStatins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy | Atorvastatin Alzheimer’s disease | Age ≥70 | Ph 4 | Active, not recruiting | 2 | Sep 2026 | 1 | |
| CAPPCerebral and Peripheral Perfusion Pilot Study | Atorvastatin Alzheimer’s disease | Age 40-65 | Ph 2 | Completed | 1 | Apr 2007 | 6 | |
| NCT00024531Lipitor as a Treatment for Alzheimer's Disease | Atorvastatin Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 1 | Aug 2004 | 6 |
Showing 1-5 of 5 trials